The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years

  • 0University of Toronto, Toronto, Canada. a.miller@dkfz-heidelberg.de

|

|

Summary

This summary is machine-generated.

Annual mammography screening for women aged 40-49 did not reduce breast cancer mortality. This large trial found no significant difference in deaths between screening and usual care groups.

Area Of Science

  • Oncology
  • Preventive Medicine
  • Radiology

Background

  • The effectiveness of breast cancer screening in women aged 40-49 is debated.
  • This age group presents unique challenges for screening efficacy.

Purpose Of The Study

  • To compare breast cancer mortality rates in women aged 40-49 undergoing regular screening versus those receiving standard community care.
  • To evaluate the long-term impact of mammography, clinical breast exams, and breast self-examination instruction.

Main Methods

  • Individually randomized controlled trial involving 50,430 women aged 40-49.
  • Intervention group received annual mammography, breast physical examination, and breast self-examination instruction for 4-5 years.
  • Control group received usual community care after an initial examination and instruction.

Main Results

  • No significant reduction in breast cancer mortality was observed in the screening group compared to the usual care group (rate ratio 1.06).
  • The screening group had a higher incidence of invasive and in situ breast cancer diagnoses.
  • Mammography successfully detected nonpalpable and small invasive tumors.

Conclusions

  • Four to five annual screenings did not decrease breast cancer mortality in women aged 40-49 over 11-16 years.
  • The study suggests that significant mortality reduction (≥20%) from this screening regimen in this age group is unlikely.

Related Concept Videos